Technology
Health
Pharmaceutical

Assembly Biosciences

$15.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.36 (-2.33%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell ASMB and other stocks, options, ETFs, and crypto commission-free!

About

Assembly Biosciences, Inc. Common Stock, also called Assembly Biosciences, is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. Read More It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin on October 7, 2005 and is headquartered in Carmel, IN.

Employees
95
Headquarters
Carmel, Indiana
Founded
2005
Market Cap
395.00M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
246.69K
High Today
$15.29
Low Today
$14.79
Open Price
$15.29
Volume
85.48K
52 Week High
$48.91
52 Week Low
$13.13

Collections

Technology
Health
Pharmaceutical
Biotechnology
Therapy
US
North America

News

Yahoo FinanceMay 9

Assembly Biosciences Reports Q1 Loss, Tops Revenue Estimates

Assembly Biosciences (ASMB) delivered earnings and revenue surprises of 1.87% and 1.89%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

35
Yahoo FinanceMay 9

Here’s What Hedge Funds Think About Assembly Biosciences Inc (ASMB)

With the fourth-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the first quarter.

35
Yahoo FinanceApr 29

Analysts Estimate Assembly Biosciences (ASMB) to Report a Decline in Earnings: What to Look Out for

232

Earnings

-$1.30
-$0.90
-$0.51
-$0.11
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$1.04 per share
Actual
-$1.05 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.